More articles from Letters to the Editor
- Prostate cancer screening
The costs of PSA testing—both financial and to the patient’s well-being—are not worth it.
- In Reply: Prostate cancer screening
The debate about screening remains fraught, and passions run high on both sides.
- COVID-19 coagulopathy
Skepticism of high-intensity prophylaxis for patients with D-dimer ≥ 3.0 µg/mL.
- Assessing stable coronary artery disease
Differences between the coronary calcium score and CT coronary angiography